Home Cart 0 Sign in  

[ CAS No. 54325-28-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 54325-28-9
Chemical Structure| 54325-28-9
Structure of 54325-28-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 54325-28-9 ]

Related Doc. of [ 54325-28-9 ]

Alternatived Products of [ 54325-28-9 ]

Product Details of [ 54325-28-9 ]

CAS No. :54325-28-9 MDL No. :MFCD00061632
Formula : C25H26O6 Boiling Point : -
Linear Structure Formula :- InChI Key :WMNZCEKHTHLIRQ-SJSRKZJXSA-N
M.W : 422.47 Pubchem ID :54438697
Synonyms :

Calculated chemistry of [ 54325-28-9 ]

Physicochemical Properties

Num. heavy atoms : 31
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.28
Num. rotatable bonds : 6
Num. H-bond acceptors : 6.0
Num. H-bond donors : 4.0
Molar Refractivity : 113.81
TPSA : 99.38 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.41 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.63
Log Po/w (XLOGP3) : 2.07
Log Po/w (WLOGP) : 1.69
Log Po/w (MLOGP) : 1.34
Log Po/w (SILICOS-IT) : 2.21
Consensus Log Po/w : 2.19

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.8
Solubility : 0.0674 mg/ml ; 0.00016 mol/l
Class : Soluble
Log S (Ali) : -3.79
Solubility : 0.0691 mg/ml ; 0.000164 mol/l
Class : Soluble
Log S (SILICOS-IT) : -5.2
Solubility : 0.00265 mg/ml ; 0.00000627 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 4.88

Safety of [ 54325-28-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 54325-28-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 54325-28-9 ]
  • Downstream synthetic route of [ 54325-28-9 ]

[ 54325-28-9 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 50-99-7 ]
  • [ 76-83-5 ]
  • [ 54325-28-9 ]
YieldReaction ConditionsOperation in experiment
88% at 80℃; for 4 h; To glucose (5g; 0.0277 mole) as a suspension in pyridine (50 mL) was added trityl chloride and stirred at 8O0C for about 4 hours. The completion of the reaction was checked by TLC using dichloromethane: methanol (85:15). The reaction was quenched with water (100 mL) and extracted with dichloromethane (150 ml x 2). The organic layer was washed with saturated solution of sodium bicarbonate and water, dried over anhydrous sodium sulfate and the solvent was removed by rotory evaporator. Trityl Chloride and pyridine were removed by triturating with hexane: diethyl ether mixture (10OmL) to afford the desired product (10.3 g; 88percent), LC-MS gave the M+ at 446 amu in accordance with the structure.
Reference: [1] Patent: WO2007/54977, 2007, A2, . Location in patent: Page/Page column 21
[2] Patent: KR101595939, 2016, B1, . Location in patent: Paragraph 0102-0103
  • 2
  • [ 2280-44-6 ]
  • [ 76-83-5 ]
  • [ 54325-28-9 ]
Reference: [1] Tetrahedron, 2007, vol. 63, # 40, p. 10042 - 10053
[2] Tetrahedron Letters, 1989, vol. 30, # 1, p. 35 - 38
[3] Carbohydrate Research, 1995, vol. 279, p. 281 - 291
[4] Tetrahedron Letters, 1996, vol. 37, # 23, p. 4015 - 4018
[5] Chemical and Pharmaceutical Bulletin, 1997, vol. 45, # 4, p. 626 - 630
[6] Carbohydrate Research, 1997, vol. 303, # 1, p. 1 - 15
[7] Carbohydrate Research, 1997, vol. 301, # 3-4, p. 123 - 143
[8] Journal of the American Chemical Society, 1999, vol. 121, # 51, p. 12196 - 12197
[9] Organic Letters, 2009, vol. 11, # 4, p. 939 - 942
[10] Journal of Medicinal Chemistry, 2011, vol. 54, # 5, p. 1481 - 1489
[11] Molecules, 2013, vol. 18, # 9, p. 11198 - 11218
[12] Journal of Labelled Compounds and Radiopharmaceuticals, 2014, vol. 57, # 14, p. 737 - 743
[13] Organic and Biomolecular Chemistry, 2017, vol. 15, # 23, p. 5025 - 5032
[14] Patent: CN107286207, 2017, A, . Location in patent: Paragraph 0017
  • 3
  • [ 492-62-6 ]
  • [ 76-83-5 ]
  • [ 54325-28-9 ]
Reference: [1] Patent: WO2006/115312, 2006, A1, . Location in patent: Page/Page column 20
[2] Patent: US2008/39421, 2008, A1, . Location in patent: Page/Page column 4; 8
Same Skeleton Products
Historical Records